The synergistic effect of simultaneous addition of retinoic acid and vitamin D3 on the in-vitro differentiation of human promyelocytic leukemia cell lines could be efficiently transposed in vivo.
Both human cell lines HL-60 and AML-193 exhibit a myeloblastic and promyelocytic morphology, respectively, but may be regarded as bipotent leukemic precursors. They can be triggered to differentiate to either granulocytes or monocytes upon retinoic acid (RA) or 1,25-dihydroxyvitamin D (D3) addition, respectively. We have investigated the effect of combined addition of these chemical inducers on the in-vitro differentiation of both cell lines. RA and D3 added together exert synergistic effects on the in-vitro maturation of these myeloid cell lines. Interestingly, the additive effects were lost if the cells were incubated with the inducers added at sequential times. The synergistic effect could be transposed in vivo and could be clinically significant in the treatment of the promyelocytic leukemia. This clinical strategy may help to prevent retinoic acid resistance or to overcome it in patients relapsed after RA therapy and usually unresponsive to a reinduction therapy with RA alone.
Camagna
A
A
Institute for Clinical Medicine (II), University La Sapienza, Rome, Italy.
Testa
U
U
Masciulli
R
R
Barberi
T
T
Samoggia
P
P
Tritarelli
E
E
Pustorino
E
E
Cipollone
L
L
Ciancio
L
L
del Duca
P
P
Dionisi
S
S
del Vecchio
L R
LR
Misasi
G
G
de Martinis
C
C
Peschle
C
C
D002454:Cell Differentiation / Q000187:drug effects; D002762:Cholecalciferol / Q000008:administration & dosage*; D004351:Drug Resistance; D004357:Drug Synergism; D018922:HL-60 Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D008954:Models, Biological; D014212:Tretinoin / Q000008:administration & dosage*; D014407:Tumor Cells, Cultured
D002762:Cholecalciferol; D014212:Tretinoin